How can I find financial assistance for patients with Revlimid?
BMS Access Support ® can help identify financial assistance programs for eligible patients who have been prescribed REVLIMID and who need help managing the cost of treatment. The appropriate program will depend on the patient’s coverage.
Is Revlimid a registered trademark of Celgene?
REVLIMID ®, POMALYST ®, POMALYST REMS ®, IMiD ®, and associated logos are registered trademarks of Celgene Corporation, a Bristol-Myers Squibb Company. Access Support ® and the related logo are registered trademarks of Bristol-Myers Squibb Company. Other trademarks are property of their respective owners. Do not use REVLIMID during pregnancy.
Where can I find more information about Celgene REMS programs?
If you would like to obtain more information about any of the Celgene-administered REMS programs, please click on the program name below: www.LenalidomideREMS.com, to learn more about the Lenalidomide REMS program. www.POMALYSTREMS.com, to learn more about the POMALYST REMS ® program.
Is Revlimid covered by insurance?
Depending on your patient’s insurance situation, there are programs and organizations that may help for REVLIMID. For eligible patients with commercial or private insurance (including healthcare exchanges),* co-pay responsibility for REVLIMID is reduced to $25 (subject to annual benefit limit).
What is the monthly cost of Revlimid?
Celgene launched Revlimid in 2005 at a price of $215 per pill. After more than 20 price hikes, the drug now costs $763 per pill, or $16,023 per month.
How do you get Revlimid?
REVLIMID is only available through a select network of specialty pharmacies due to a restricted distribution program called Lenalidomide REMS. These specialty pharmacies help to manage the handling and shipping of REVLIMID and may provide additional resources.
What tier drug is Revlimid?
What drug tier is Revlimid typically on? Medicare prescription drug plans typically list Revlimid on Tier 5 of their formulary. Generally, the higher the tier, the more you have to pay for the medication.
How long can you take Revlimid?
You won't take the drug on days 22 to 28. Revlimid can be taken for up to 12 cycles. Your doctor will likely prescribe Revlimid with the medication rituximab (Truxima, Rituxan).
Is REVLIMID chemo?
Revlimid | Chemotherapy Drug Information | Chemocare.com.
Is there a generic brand of REVLIMID?
Generic Versions of Revlimid and Velcade Now Available for Patients With Multiple Myeloma. In the first half of 2022, the Food and Drug Administration (FDA) approved generic versions of the two drugs most commonly used as the backbone of multiple myeloma combination therapies, Revlimid and Velcade.
When does Revlimid go off patent?
Revlimid is currently protected by 12 patents, including one that expires in 2019 and another—covering the crystal polymorph form of the drug—that only expires in 2026 and others are pending.
What is the cost of Revlimid in Canada?
In Canada, Revlimid costs between $8,000 and $10,000 Canadian per month, depending on dosage.
Does Medicare cover multiple myeloma treatments?
"As most patients with myeloma in the United States are covered by Medicare, our results have important implications both for the clinicians who care for these patients and for health-care policy that tackles coverage of oral and parenteral anticancer therapy."
What is the success rate of Revlimid?
Patients who took REVLIMID and dexamethasone continuously had a 75% response rate compared to 73% of patients who took REVLIMID and dexamethasone for only 18 months and 62% of patients who took the combination of melphalan, prednisone, and thalidomide.
What are the long term effects of taking Revlimid?
It's possible that Revlimid can cause long-term side effects. For example, this medication may cause: liver problems, such as liver failure. other types of cancer, such as skin cancer or leukemia.
What happens if you touch Revlimid?
Serious skin reactions can happen with REVLIMID and may cause death. Call your healthcare provider right away if you have any skin reaction while taking REVLIMID. Tumor lysis syndrome (TLS). TLS is caused by the fast breakdown of cancer cells.
How is Revlimid dispensed?
Recommended Dosage For Mantle Cell Lymphoma The recommended starting dose of REVLIMID is 25 mg/day orally on Days 1-21 of repeated 28-day cycles for relapsed or refractory mantle cell lymphoma. Treatment should be continued until disease progression or unacceptable toxicity.
What does Revlimid do for multiple myeloma?
Revlimid, also known as lenalidomide, is an oral drug that is used for the treatment of multiple myeloma. It is part of a class of drugs called immunomodulatory drugs (IMiDs), which work against cancer cells partly by supporting the function of the immune system. Revlimid is manufactured by Bristol Myers Squibb.
What are the long term effects of Revlimid?
It's possible that Revlimid can cause long-term side effects. For example, this medication may cause: liver problems, such as liver failure. other types of cancer, such as skin cancer or leukemia.
Can you touch Revlimid?
chew, or open your capsules. Do not open the REVLIMID capsules or handle them any more than needed. If you touch a broken REVLIMID capsule or the medicine in the capsule, wash the area of your body with soap and water.
How to contact Celgene?
Email us at [email protected] or fax 1-800-822-2496.
Is Revlimid recommended for MCL?
REVLIMID ® is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib. REVLIMID is not indicated and is not recommended for the treatment of patients with CLL outside of controlled clinical trials.
Patients With Commercial (Private) Insurance
The BMS Oncology Co-Pay Assistance Program helps commercially insured patients who have been prescribed select BMS medications with out-of-pocket deductibles, co-pays, or co-insurance requirements. Eligible patients may pay as little as $10 per one-month supply, up to a maximum of $15,000 per calendar year.
Patients With Insurance Through Federal Healthcare Programs
Patients insured through Federal Healthcare Programs are not eligible for co-pay assistance programs sponsored by Bristol Myers Squibb.
Patients Without Prescription Drug Coverage or Who Are Underinsured
For patients without prescription drug insurance or for patients who are underinsured, BMS Access Support can make a referral to independent charitable foundations that may be able to help.
How BMS Access Support May Help
Find out how BMS can work with patients and their healthcare providers to help access a prescribed BMS medication.
Financial Support Options
There may be programs and services that could help with the cost of treatment. Learn about what options are available.
Additional Resources
We provide videos, tools, and other resources that may help with your access and reimbursement needs.
How to contact Revlimid?
Your experience could help fellow patients, caregivers, and healthcare providers. To contact us, call 1-800-657-9801 or email [email protected].
What do you need to know before prescribing Revlimid?
Before you begin taking REVLIMID, you must read and agree to all of the instructions in the REVLIMID REMS ® program. Before prescribing REVLIMID, your healthcare provider will explain the REVLIMID REMS program to you and have you sign the Patient-Physician Agreement Form.
What is Revlimid used for?
REVLIMID ® (lenalidomide) is a prescription medicine, used to treat adults with multiple myeloma (MM) in combination with the medicine dexamethasone, or as maintenance treatment after autologous hematopoietic stem cell transplantation (a type of stem cell transplant that uses your own stem cells).
Is Revlimid a prescription?
REVLIMID ® (lenalidomide) is a prescription medicine, used to treat adults with multiple myeloma (MM) in combination with the medicine dexamethasone, or as maintenance treatment after autologous hematopoietic stem cell transplantation (a type of stem cell transplant that uses your own stem cells). REVLIMID should not be used to treat people who have chronic lymphocytic leukemia (CLL) unless they are participants in a controlled clinical trial. It is not known if REVLIMID is safe and effective in children.
How old do you have to be to sign up for Revlimid?
Must be 18 years of age or older to sign up. Please see Privacy Policy to learn more about Bristol Myers Squibb's use of submitted information.
Is Revlimid safe for babies?
VO: REVLIMID (lenalidomide) may cause serious side effects, including risk to unborn babies, risk of low blood counts and blood clots. There are safety considerations to be aware of with REVLIMID. That is why REVLIMID is only available through a restricted distribution program, REVLIMD REMS ®. Please listen for important safety information throughout this video.
Can you breastfeed with Revlimid?
are breastfeeding. Do not breastfeed during treatment with REVLIMID. It is not known if REVLIMID passes into your breast milk and can harm your baby.
Contraindications
Warnings and Precautions
- Embryo-Fetal Toxicity: See Boxed WARNINGS. 1. Females of Reproductive Potential: See Boxed WARNINGS. 2. Males: Lenalidomide is present in the semen of patients receiving the drug. Males must always use a latex or synthetic condom during any sexual contact with females of reproductive potential while taking REVLIMID and for up to 4 weeks after discontinuing REVLIMI…
Multiple Myeloma
- In newly diagnosed: The most frequently reported Grade 3 or 4 reactions included neutropenia, anemia, thrombocytopenia, pneumonia, asthenia, fatigue, back pain, hypokalemia, rash, cataract, lymphop...
- The most common adverse reactions reported in ≥20% (Arm Rd Continuous): diarrhea (45%), anemia (44%), neutropenia (35%), fatigue (33%), back pain (32%), asthenia (28%), insomnia (2…
- In newly diagnosed: The most frequently reported Grade 3 or 4 reactions included neutropenia, anemia, thrombocytopenia, pneumonia, asthenia, fatigue, back pain, hypokalemia, rash, cataract, lymphop...
- The most common adverse reactions reported in ≥20% (Arm Rd Continuous): diarrhea (45%), anemia (44%), neutropenia (35%), fatigue (33%), back pain (32%), asthenia (28%), insomnia (28%), rash (26%),...
- Maintenance Therapy Post Auto-HSCT:The most frequently reported Grade 3 or 4 reactions in ≥20% (REVLIMID arm) included neutropenia, thrombocytopenia, and leukopenia. The serious adverse reactions o...
- The most frequently reported adverse reactions in ≥20% (REVLIMID arm) across both mainte…
Drug Interactions
- Periodically monitor digoxin plasma levels due to increased Cmaxand AUC with concomitant REVLIMID therapy. Patients taking concomitant therapies such as ESAs or estrogen-containing therapies may have an increased risk of thrombosis. It is not known whether there is an interaction between dexamethasone and warfarin. Close monitoring of PT and INR is recommen…
Use in Specific Populations
- PREGNANCY: See Boxed WARNINGS:If pregnancy does occur during treatment, immediately discontinue the drug and refer patient to an obstetrician/gynecologist experienced in reproductive toxicity for f...
- LACTATION: There is no information regarding the presence of lenalidomide in human milk, the effects of REVLIMID on the breastfed infant, or the effects of REVLIMID on milk productio…
- PREGNANCY: See Boxed WARNINGS:If pregnancy does occur during treatment, immediately discontinue the drug and refer patient to an obstetrician/gynecologist experienced in reproductive toxicity for f...
- LACTATION: There is no information regarding the presence of lenalidomide in human milk, the effects of REVLIMID on the breastfed infant, or the effects of REVLIMID on milk production. Because many...
- RENAL IMPAIRMENT: Adjust the starting dose of REVLIMID based on creatinine clearance value and for patients on dialysis.
Contraindications
- Pregnancy:REVLIMID can cause fetal harm when administered to a pregnant female and is contraindicated in females who are pregnant. If this drug is used during pregnancy or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential risk to the fetus. Severe Hypersensitivity Reactions:REVLIMID is contraind...
Warnings and Precautions
- Embryo-Fetal Toxicity: See Boxed WARNINGS. 1. Females of Reproductive Potential: See Boxed WARNINGS. 2. Males: Lenalidomide is present in the semen of patients receiving the drug. Males must always use a latex or synthetic condom during any sexual contact with females of reproductive potential while taking REVLIMID and for up to 4 weeks after discontinuing REVLIMI…
Adverse Reactions
- Mantle Cell Lymphoma 1. Grade 3 and 4 adverse events reported in ≥5% of patients treated with REVLIMID in the MCL trial (N=134) included neutropenia (43%), thrombocytopenia (28%), anemia (11%), pneumonia (9%), leukopenia (7%), fatigue (7%), diarrhea (6%), dyspnea (6%), and febrile neutropenia (6%). 2. Adverse events reported in ≥15% of patients treated with REVLIMID in the M…
Drug Interactions
- Periodically monitor digoxin plasma levels due to increased Cmaxand AUC with concomitant REVLIMID therapy. Patients taking concomitant therapies such as ESAs or estrogen-containing therapies may have an increased risk of thrombosis. It is not known whether there is an interaction between dexamethasone and warfarin. Close monitoring of PT and INR is recommen…
Use in Specific Populations
- PREGNANCY: See Boxed WARNINGS:If pregnancy does occur during treatment, immediately discontinue the drug and refer patient to an obstetrician/gynecologist experienced in reproductive toxicity for f...
- LACTATION: There is no information regarding the presence of lenalidomide in human milk, the effects of REVLIMID on the breastfed infant, or the effects of REVLIMID on milk productio…
- PREGNANCY: See Boxed WARNINGS:If pregnancy does occur during treatment, immediately discontinue the drug and refer patient to an obstetrician/gynecologist experienced in reproductive toxicity for f...
- LACTATION: There is no information regarding the presence of lenalidomide in human milk, the effects of REVLIMID on the breastfed infant, or the effects of REVLIMID on milk production. Because many...
- RENAL IMPAIRMENT: Adjust the starting dose of REVLIMID based on creatinine clearance value and for patients on dialysis.